Disability UK Online Health Journal - All In One Business In A Box - Forum - Business Directory - Useful Resources

Category: Seizures

Progressive Multifocal Leukoencephalopathy (PML)

Brown and Cream Landscape Image Of A Vintage Typewriter With The Wording 'Multiple Sclerosis (MS) typed On Paper. Image Credit: PhotoFunia.com Category: Vintage- Typewriter.
Image Description: Brown and Cream Landscape Image Of A Vintage Typewriter With The Wording ‘Multiple Sclerosis (MS) typed On Paper. Image Credit: PhotoFunia.com Category: Vintage- Typewriter.


What Is Progressive Multifocal Leukoencephalopathy (PML) and its connection with Multiple Sclerosis (MS)

Progressive Multifocal Leukoencephalopathy (PML) is a rare but serious brain infection caused by the JC virus, a common virus that typically remains dormant in most people. However, in individuals with weakened immune systems, it can reactivate, leading to PML—a disease that damages the white matter in the brain and disrupts communication between brain cells. This infection can lead to severe neurological symptoms and is often life-threatening, with rapid progression and limited treatment options. Among the populations at risk for PML are people with Multiple Sclerosis (MS), particularly those undergoing certain treatments that suppress immune function.

Understanding Progressive Multifocal Leukoencephalopathy (PML)

PML is caused by the JC (John Cunningham) virus, a typically harmless virus that about 70–90% of the population carries without issue. For most, the immune system keeps this virus in check, often in the kidneys, and it remains asymptomatic throughout life. However, when immune function is severely compromised—such as in cases of HIV/AIDS, cancer treatments, or certain immunosuppressive therapies—the JC virus can become reactivated, cross the blood-brain barrier, and infect the brain. This results in demyelination, a process where the protective myelin sheath surrounding nerve cells is damaged, leading to white matter lesions and severe neurological impairment.

Symptoms of PML include:

  • Weakness or paralysis in parts of the body
  • Visual disturbances
  • Cognitive impairments
  • Difficulty speaking or understanding language
  • Seizures

The symptoms vary depending on which areas of the brain are affected, and the disease can progress rapidly, leading to severe disability or death if not managed.

The Connection Between PML and Multiple Sclerosis (MS)

Multiple Sclerosis (MS) is an autoimmune disease where the body’s immune system mistakenly attacks the central nervous system, leading to inflammation, demyelination, and damage to nerve fibers. Many MS patients are prescribed immunomodulatory drugs to manage inflammation and prevent MS relapses. However, certain MS medications, particularly those that alter immune function, have been linked to an increased risk of PML.

The connection lies in the immune-suppressing or modulating effects of some MS treatments. By altering the immune system to reduce MS symptoms, these medications may inadvertently create a favorable environment for the JC virus to reactivate, leading to PML.

MS Medications and PML Risk

The following MS medications are particularly associated with PML risk:

  1. Natalizumab (Tysabri): One of the most effective drugs for MS, Natalizumab works by inhibiting immune cells from entering the brain and spinal cord, thus reducing inflammation. However, this also reduces the brain’s defenses against infections like PML. The risk of PML increases with longer treatment durations, especially in patients who test positive for the JC virus antibody.
  2. Fingolimod (Gilenya): This oral medication reduces the movement of immune cells from lymph nodes, limiting their ability to cause inflammation in the CNS. Though the risk of PML with Fingolimod is lower than with Natalizumab, several cases have still been reported, particularly in those with prior exposure to immunosuppressive drugs.
  3. Dimethyl Fumarate (Tecfidera): While the PML risk associated with Dimethyl Fumarate is lower, cases have occurred, especially in patients with low lymphocyte counts, a condition that weakens the immune system’s ability to fight infections.
  4. Ocrelizumab (Ocrevus): A newer treatment, Ocrelizumab, depletes specific B cells, which play a role in the immune response. Although the risk of PML with Ocrelizumab is considered lower, it’s still a potential risk, especially in those with JC virus positivity.

Who Is at Higher Risk?

PML risk factors among MS patients include:

  • JC Virus Antibody Positivity: Testing positive for the JC virus antibody indicates prior exposure to the virus, which raises the risk of reactivation.
  • Previous Immunosuppressive Therapy: Patients who have used immunosuppressants for an extended period are at a higher risk.
  • Duration of Treatment: The longer the treatment duration with certain MS drugs, such as Natalizumab, the higher the risk of PML.
  • Low Immune Cell Count: Reduced immune cells, particularly lymphocytes, are another risk factor, as these cells are essential for controlling infections.

Symptoms of PML in MS Patients

The symptoms of PML can sometimes overlap with MS symptoms, making diagnosis challenging. However, any new or worsening neurological symptoms, such as increased difficulty with movement, coordination, speech, or cognition, may be a red flag for PML and should prompt immediate medical attention. MRI scans and lumbar puncture tests (to detect JC virus in the cerebrospinal fluid) are often used to diagnose PML.

Preventing and Monitoring for PML in MS Patients

For MS patients on treatments associated with PML risk, regular monitoring is essential. Steps to reduce risk include:

  • JC Virus Antibody Testing: This test can help predict PML risk. Patients who test positive for JC virus antibodies may consider alternative treatments.
  • Regular Blood Tests: Monitoring lymphocyte counts helps detect any signs of immune suppression.
  • Frequent MRI Scans: Regular MRI scans help detect any early signs of brain changes related to PML, allowing for earlier intervention if needed.
  • Risk-Benefit Assessment: Doctors and patients should carefully weigh the risks and benefits of immunosuppressive drugs, particularly if other treatment options are available.

Treatment Options for PML

Treating PML is challenging, as there is no cure. Management typically involves stopping the immunosuppressive therapy to allow the immune system to recover and fight the JC virus. For instance, patients on Natalizumab may undergo plasma exchange to clear the drug from their system more quickly. Some experimental therapies, such as immunotherapy, are being explored, but the prognosis remains guarded.

Conclusion

Progressive Multifocal Leukoencephalopathy (PML) is a severe, life-threatening condition that poses a particular risk for MS patients using immunosuppressive therapies. Awareness of the risk factors, regular monitoring, and open communication with healthcare providers are essential for MS patients considering or currently using these medications. By staying informed and vigilant, patients can make safer, more informed choices about their treatment options and work closely with their medical team to minimize PML risk while managing MS effectively.

Final Note From The Author: I had my annual routine consultation today and received some concerning news—my neurologist is considering putting me on Ocrelizumab (Ocrevus). Given that I’ve been living with Multiple Sclerosis for the past eight years and was initially treated with Alemtuzumab, I decided to do some research on this new option. My relapses have become more frequent, so they’re exploring alternatives, though they’ll need to review my MRI results before making a final decision. Ocrelizumab is an infusion treatment given every six months, which sounds manageable, but I’m particularly concerned about the risk of contracting Progressive Multifocal Leukoencephalopathy (PML), a rare but serious infection linked to some MS treatments. If the risk of PML is significant, I may consider refusing treatment altogether, as I’m wary of the potential complications.



Guest Writers Needed – On Health!

Empty Canvas
Content Coming Soon!

GUEST WRITERS NEEDED!



Boots Logo

UK HEALTH & BEAUTY


We are in the process of building our own directory of A-Z illnesses and disabilities. If you happen to land on this page we encourage you to visit the NHS website about the topic in our category.


Awaiting Content On Health!

It is vital to have platforms that champion inclusivity and diversity, bringing stories and experiences from all walks of life to the forefront. The Disabled Entrepreneur – Disability UK Online Journal is one such platform dedicated to representing the experiences, insights, and accomplishments of disabled individuals. However, like an empty canvas waiting for an artist’s brush, our pages are currently awaiting content. We’re excited to invite guest writers to share their knowledge and perspectives on all health topics, from A to Z. If you have landed on this page that means the category needs content.

A Platform for the Disabled Community

The Disabled Entrepreneur – Disability UK Online Journal is more than just a publication; it’s a celebration of resilience, innovation, and success in the face of adversity. Disabled entrepreneurs, activists, healthcare professionals, and advocates have a valuable platform to share their insights and experiences. This journal is a space where stories and knowledge intersect to form a resource-rich hub for the entire disabled community.

Why Your Contribution Matters

Sharing your expertise and experiences on this platform can have a profound impact in several ways:

  1. Inspiration and Representation: Your stories and knowledge can inspire others in the disabled community. Representation matters, and your contribution can pave the way for others to follow in your footsteps.
  2. Education: The world of disabilities is vast and diverse. By contributing to the journal, you can educate the public and offer insights into topics such as disability rights, accessible technology, healthcare, adaptive sports, and more.
  3. Fostering Inclusivity: By sharing your perspective, you help break down barriers and stigmas surrounding disabilities. The more we understand each other, the more inclusive our society can become.
  4. Professional Growth: Becoming a guest writer for a reputable platform like this can enhance your professional profile and provide valuable networking opportunities.

Topics We’re Looking For

At the Disabled Entrepreneur – Disability UK Online Journal, we aim to cover a wide range of health topics and disability-related subjects. Our pages are open to contributions that span the A to Z of health and disability, including but not limited to:

  • Accessible Technology: Innovations in assistive devices and technology.
  • Mental Health: Strategies for managing mental health while navigating life with a disability.
  • Policy and Advocacy: Insights into disability rights and policy changes.
  • Entrepreneurship and Business: Stories of successful disabled entrepreneurs and startup guidance.
  • Inclusive Education: Strategies for creating inclusive learning environments.
  • Wellness and Healthcare: Tips on maintaining physical and mental health.

Browse our categories to see what content we need.

If you’re interested in sharing your knowledge, experiences, or insights on disability-related topics, we invite you to become a guest writer for the Disabled Entrepreneur – Disability UK Online Journal. To get started, simply follow these steps:

  1. Pitch Your Idea: Send us a brief pitch outlining your proposed topic to [email address]. Ensure that it aligns with our vision and mission.
  2. Write Your Article: Once your pitch is approved, start working on your article. Our editorial team will be available to provide guidance and feedback.
  3. Submit Your Article: When your article is ready, submit it for review.
  4. Engage with Our Community: We encourage our guest writers to engage with our readers through comments and discussions, offering valuable insights and answering questions.

Conclusion

The Disabled Entrepreneur – Disability UK Online Journal is not just a publication; it’s a collective voice that celebrates the achievements and experiences of the disabled community. We believe in the power of collective knowledge, and we invite you to be a part of our mission. Your contribution can be a stepping stone for others and an invaluable resource for the world. Join us in filling our pages with content that resonates, educates, and inspires.

As a guest writer, you’ll gain exposure and the chance to build a portfolio of content. We also offer backlinks to your personal or professional website, enhancing your online presence. By sharing your knowledge with our community, you’re not only enriching our journal but also empowering individuals within the disabled community and beyond.

At Disabled Entrepreneur – Disability UK, we are committed to supporting our talented writers. Our goal is to create a platform that compensates contributors once we reach a level of traffic that sustains such payments. As we grow, we are exploring the possibility of introducing a paywall system. This approach will help us continue to provide quality content while rewarding our dedicated writers for their valuable contributions. Your words and expertise are an essential part of our journey, and we look forward to a future where we can reciprocate your efforts more substantially.


#guestposts #guestwriting #articlewriting #backlinks #portfoliobuilding #illnesses #disabilities #disabledentrepreneur.


ADVERTISEMENTS


Boots Logo

UK HEALTH & BEAUTY


UK Banner

ONLINE THERAPY


ONLINE DOCTORS



Blue Butterfly Logo

Epilepsy (SUDEP)

Image Credit: https://healthmatters.nyp.org/what-to-know-about-epilepsy/

Epilepsy (SUDEP)

Epilepsy is a neurological disorder that affects the central nervous system, causing seizures or convulsions. Seizures can be triggered by various factors, such as genetic mutations, brain damage, and infections. Epilepsy affects millions of people worldwide, and it is estimated that one in 26 people will develop epilepsy at some point in their lives.

Although epilepsy is a well-known disorder, few people are aware of the associated risk of sudden unexpected death in epilepsy (SUDEP). SUDEP is a rare but potentially fatal complication of epilepsy, which is defined as the sudden, unexpected, and unexplained death of a person with epilepsy, without a clear cause of death after a post-mortem examination.

The exact cause of SUDEP is not fully understood, but it is thought to be due to a combination of factors. It is believed that the seizure activity in the brain can trigger changes in the heart rate and breathing, which can lead to cardiac arrest or respiratory failure. Additionally, other factors, such as sleep deprivation, alcohol consumption, and certain medications, may increase the risk of SUDEP.

SUDEP is a devastating and tragic event, not only for the person affected but also for their family and loved ones. It is estimated that SUDEP accounts for up to 18% of all deaths in people with epilepsy, with the highest risk occurring in those with uncontrolled seizures. Therefore, it is important to raise awareness about SUDEP, and to encourage people with epilepsy to seek medical attention and adhere to their treatment plan to minimize the risk of seizures.

There are several strategies that can be used to reduce the risk of SUDEP. The most effective strategy is to achieve seizure control through medication, surgery, or other treatments. People with epilepsy should work closely with their healthcare provider to develop a personalized treatment plan that takes into account their individual needs and medical history. Additionally, lifestyle modifications, such as avoiding triggers that can cause seizures, getting enough sleep, and avoiding alcohol and drugs, can help reduce the risk of SUDEP.

It is also important to educate people with epilepsy and their families about the signs and symptoms of SUDEP, so they can seek immediate medical attention if they suspect an episode of SUDEP. Some of the warning signs of SUDEP include a seizure lasting longer than usual, difficulty breathing, abnormal heart rate, and loss of consciousness.

Conclusion

SUDEP is a rare but potentially fatal complication of epilepsy. It is important to raise awareness about SUDEP and to encourage people with epilepsy to seek medical attention and adhere to their treatment plan to minimize the risk of seizures. Achieving seizure control through medication, surgery, or other treatments, and making lifestyle modifications can help reduce the risk of SUDEP. It is also important to educate people with epilepsy and their families about the signs and symptoms of SUDEP so that they can seek immediate medical attention if necessary.

ADVERTISEMENT

Cymru Marketing Banner AD

#suddendeath #epilepsy #sudep #convulsions #seizures #neurologicaldisorder #centralnervoussystem #respiratoryfailure #cardiacarrest